{
    "clinical_study": {
        "@rank": "10041", 
        "arm_group": [
            {
                "arm_group_label": "Vedolizumab 300mg", 
                "arm_group_type": "Experimental", 
                "description": "Intravenous Vedolizumab (300 mg) administered at Weeks 0, 2, and 6 and every 8 weeks thereafter."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Vedolizumab Placebo. Intravenous infusion at Weeks 0, 2, and 6 and every 8 weeks thereafter"
            }
        ], 
        "brief_summary": {
            "textblock": "This  study is a phase 3, multicenter, randomized, double-blinded, placebo-controlled,\n      parallel-group study to examine the efficacy, safety, and pharmacokinetics of MLN0002\n      (Vedolizumab) in induction and maintenance therapy in Japanese patients with  moderately or\n      severely active ulcerative colitis."
        }, 
        "brief_title": "Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis", 
        "completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Ulcerative Colitis", 
        "condition_browse": {
            "mesh_term": [
                "Colitis", 
                "Colitis, Ulcerative", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study is a Phase 3, multicenter, randomized, double-blinded, placebo-controlled,\n      parallel-group study to examine the efficacy, safety, and pharmacokinetics of intravenous\n      Vedolizumab (300 mg) infusion in induction and maintenance therapy in Japanese patients with\n       moderately or severely active ulcerative colitis/"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients aged 15 to 80 years (inclusive) at the time of consent\n\n          2. Patients with a diagnosis of total or left-sided colitis established based on the\n             Revised Diagnostic Criteria for Ulcerative Colitis issued by Research Group for\n             Intractable Inflammatory Bowel Disease Designated as Specified Disease by the\n             Ministry of Health, Labor and Welfare of Japan (2012) at least 6 months before the\n             start of administration of study drug.\n\n          3. Patients with moderately or severely active ulcerative colitis as determined by\n             baseline complete Mayo score of 6 to 12 (inclusive) with an endoscopic subscore of \u22652\n\n          4. In case of the patients who meet any of the following criteria; patients with \u22658-year\n             history of total or left-sided colitis, patients aged \u2265 50 years, or patients with a\n             first-degree family history of colon cancer, those whom the complication of colon\n             cancer or dysplasia was ruled out by total colonoscopy at the start of study drug\n             administration (Or the results from total colonoscopy performed within 1 year before\n             giving consent are available).\n\n          5. Patients meeting the criteria for treatment failure below with at least one of the\n             following agents received within the previous 5 year period before giving consent.\n\n        Corticosteroids\n\n          -  Resistance\n\n          -  Dependence\n\n          -  Intolerance Immunomodulators (azathioprine or 6-mercaptopurine)\n\n          -  Refractory\n\n          -  Intolerance Anti-TNF\u03b1 antibodies\n\n          -  Inadequate response\n\n          -  Loss of response\n\n          -  Intolerance\n\n        Exclusion Criteria:\n\n          -  1. Patients whose partial Mayo score decrease by 3 points or more between screening\n             and the start of study drug administration 2. Patients with an evidence of or\n             suspected abdominal abscess or toxic megacolon 3. Patients with a history of subtotal\n             or total colectomy 4. Patients with ileostomy, colostomy,or fistula, or severe\n             intestinal stenosis 5. Patients who started 5-aminosalicylic acid oral drug or\n             probiotics treatment or 30 mg/day or less of oral corticosteroids within 13 days\n             before initiation of study drug administration. If these drugs were used within 14\n             days before initiation of study drug administration, the dosage must have been\n             changed or their use discontinued within 13 days before the initiation of study drug\n             administration 6. Patients  who have received 5-aminosalicylic acid or corticosteroid\n             enemas/suppositories, intravenous corticosteroid injections, or more than 30 mg/day\n             of oral corticosteroids, medications for diarrhea-predominant irritable bowel\n             syndrome, or Chinese herbal medicine for the treatment of ulcerative colitis (e.g.,\n             Daikenchuto)  within 13 days before initiation of the study drug administration 7.\n             Patients who have received an antidiarrheal drug for at 4 or more days consecutively\n             within 13 days before initiation of the study drug administration or an antidiarrheal\n             drug within 7 days before initiation of the study drug administration 8. Patients who\n             have received azathioprine or 6-mercaptopurine within 27 days before initiation of\n             the study drug administration. However, this shall not apply to patients who have\n             received these drugs for 83 or more days before initiation of the study drug\n             administration and continued the steady dose administration of the drugs for 27 or\n             more days before initiation of the study drug administration 9. Patients  who have\n             received cyclosporin, tacrolimus, methotrexate, or tofacitinib or any study drugs for\n             treatment of ulcerative colitis within 27 days before initiation of the study drug\n             administration 10. Patients who have received adalimumab within 27 days before\n             initiation of the study drug administration or any biological drugs other than\n             adalimumab within 55 days before initiation of the study drug administration. Topical\n             administration (such as intraocular implantation for treatment of age-related\n             maculopacy) is allowed 11. Patients who have received any live vaccinations within 27\n             days before initiation of study drug administration 12. Patients who have undergone\n             intestinal resection within 27 days before initiation of study drug administration or\n             those anticipated to require intestinal resection during the study 13. Patients who\n             have received  leukocytapheresis or granulocyte apheresis within 27 days before\n             initiation of the study drug administration 14. Patients with an evidence of\n             adenomatous colonic polyps that need to be removed at the start of study drug\n             administration 15. Patients with a history or  a complication of colonic mucosal\n             dysplasia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "278", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02039505", 
            "org_study_id": "MLN0002/CCT-101", 
            "secondary_id": [
                "U1111-1151-6762", 
                "JapicCTI-142403"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Vedolizumab 300mg", 
                "description": "Vedolizumab intravenous injection", 
                "intervention_name": "Vedolizumab", 
                "intervention_type": "Drug", 
                "other_name": "MLN0002"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Vedolizumab placebo", 
                "intervention_name": "Vedolizumab placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Drug therapy", 
        "lastchanged_date": "May 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Kasugai-shi", 
                        "country": "Japan", 
                        "state": "Aichi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagoya-shi", 
                        "country": "Japan", 
                        "state": "Aichi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toyota-shi", 
                        "country": "Japan", 
                        "state": "Aichi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hirosaki-shi", 
                        "country": "Japan", 
                        "state": "Aomori"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sakura-shi", 
                        "country": "Japan", 
                        "state": "Chiba"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Matsuyama-shi", 
                        "country": "Japan", 
                        "state": "Ehime"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fukui-shi", 
                        "country": "Japan", 
                        "state": "Fukui"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chikushino-shi", 
                        "country": "Japan", 
                        "state": "Fukuoka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fukuoka-shi", 
                        "country": "Japan", 
                        "state": "Fukuoka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kitakyushu-shi", 
                        "country": "Japan", 
                        "state": "Fukuoka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kurume-shi", 
                        "country": "Japan", 
                        "state": "Fukuoka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fukuyama-shi", 
                        "country": "Japan", 
                        "state": "Hiroshima"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hatsukaichi-shi", 
                        "country": "Japan", 
                        "state": "Hiroshima"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hiroshima-shi", 
                        "country": "Japan", 
                        "state": "Hiroshima"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Asahikawa-shi", 
                        "country": "Japan", 
                        "state": "Hokkaido"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hakodate-shi", 
                        "country": "Japan", 
                        "state": "Hokkaido"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sapporo-shi", 
                        "country": "Japan", 
                        "state": "Hokkaido"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tomakomai-shi", 
                        "country": "Japan", 
                        "state": "Hokkaido"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Akashi-shi", 
                        "country": "Japan", 
                        "state": "Hyogo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Himeji-shi", 
                        "country": "Japan", 
                        "state": "Hyogo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Itami-shi", 
                        "country": "Japan", 
                        "state": "Hyogo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kobe-shi", 
                        "country": "Japan", 
                        "state": "Hyogo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nishinomiya-shi", 
                        "country": "Japan", 
                        "state": "Hyogo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Komatsu-shi", 
                        "country": "Japan", 
                        "state": "Ishikawa"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marukame-shi", 
                        "country": "Japan", 
                        "state": "Kagawa"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Takamatsu-shi", 
                        "country": "Japan", 
                        "state": "Kagawa"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kagoshima-shi", 
                        "country": "Japan", 
                        "state": "Kagoshima"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fujisawa-shi", 
                        "country": "Japan", 
                        "state": "Kanagawa"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kamakura-shi", 
                        "country": "Japan", 
                        "state": "Kanagawa"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kawasaki-shi", 
                        "country": "Japan", 
                        "state": "Kanagawa"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sagamihara-shi", 
                        "country": "Japan", 
                        "state": "Kanagawa"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yokohama-shi", 
                        "country": "Japan", 
                        "state": "Kanagawa"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kochi-shi", 
                        "country": "Japan", 
                        "state": "Kochi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kumamoto-shi", 
                        "country": "Japan", 
                        "state": "Kumamoto"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyoto-shi", 
                        "country": "Japan", 
                        "state": "Kyoto"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sendai-shi", 
                        "country": "Japan", 
                        "state": "Miyagi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagasaki-shi", 
                        "country": "Japan", 
                        "state": "Nagasaki"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beppu-shi", 
                        "country": "Japan", 
                        "state": "Ohita"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ohita-shi", 
                        "country": "Japan", 
                        "state": "Ohita"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Okayama-shi", 
                        "country": "Japan", 
                        "state": "Okayama"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moriguchi-shi", 
                        "country": "Japan", 
                        "state": "Osaka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Osaka-shi", 
                        "country": "Japan", 
                        "state": "Osaka"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sakai-shi", 
                        "country": "Japan", 
                        "state": "Osaka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suita-shi", 
                        "country": "Japan", 
                        "state": "Osaka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saga-shi", 
                        "country": "Japan", 
                        "state": "Saga"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tokorozawa-shi", 
                        "country": "Japan", 
                        "state": "Saitama"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ohtsu-shi", 
                        "country": "Japan", 
                        "state": "Shiga"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamamatsu-shi", 
                        "country": "Japan", 
                        "state": "Shizuoka"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shimotsuke-shi", 
                        "country": "Japan", 
                        "state": "Tochigi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Adachi-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bunkyo-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chiyoda-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edogawa-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minato-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinagawa-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinjuku-ku", 
                        "country": "Japan", 
                        "state": "Tokyo"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wakayama-shi", 
                        "country": "Japan", 
                        "state": "Wakayama"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shunan-shi", 
                        "country": "Japan", 
                        "state": "Yamaguchi"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kofu-shi", 
                        "country": "Japan", 
                        "state": "Yamanashi"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase III, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Examine the Efficacy, Safety, and Pharmacokinetics of Intravenous MLN0002 (300 mg) Infusion in Induction and Maintenance Therapy in Japanese Patients With Moderately or Severely Active Ulcerative Colitis", 
        "overall_contact": {
            "email": "medicalinformation@tpna.com", 
            "last_name": "Takeda Study Registration Call Center", 
            "phone": "+1-800-778-2860 (USA & EU)"
        }, 
        "overall_official": {
            "affiliation": "Takeda", 
            "last_name": "General Manager", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Percentage of patients randomized to the induction phase showing a clinical response (complete Mayo score decreased \u22653 points and \u2265 30 percent from baseline, and the rectal bleeding subscore decreased \u22651 point from baseline or is \u22641) at Week 10 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Induction phase: Clinical response at Week 10", 
                "safety_issue": "No", 
                "time_frame": "At week 10"
            }, 
            {
                "description": "Percentage of subjects randomized to the maintenance phase showing clinical remission (the complete Mayo score is \u22642 and all subscores are \u22641) at Week 60 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Maintenance Phase: Clinical remission at Week 60", 
                "safety_issue": "No", 
                "time_frame": "At Week 60"
            }, 
            {
                "description": "Tabulation of incidence of adverse events Adverse events are defined as any unfavorable and unintended signs, symptoms or diseases temporally associated with the use of a medicinal product reported from the first dose of study drug to the last dose of study drug", 
                "measure": "Advrse Events", 
                "safety_issue": "Yes", 
                "time_frame": "From baseline to 16 weeks after the last dose of study drug"
            }, 
            {
                "description": "Summary statistics for body weight at each evaluation time point.", 
                "measure": "Body Weight", 
                "safety_issue": "Yes", 
                "time_frame": "From baseline to 16 weeks after the last dose of study drug"
            }, 
            {
                "description": "Summary statistics for vital signs at each evaluation time point.", 
                "measure": "Vital signs", 
                "safety_issue": "Yes", 
                "time_frame": "From baseline to 16 weeks after the last dose of study drug"
            }, 
            {
                "description": "Summary statistics for Electrocardiogram (ECG) measurements at each evaluation time point.", 
                "measure": "Electrocardiogram (ECG)", 
                "safety_issue": "Yes", 
                "time_frame": "From baseline to 16 weeks after the last dose of study drug"
            }, 
            {
                "description": "Summary statistics for measurements of clinical laboratory test at each evaluation time point.", 
                "measure": "Clinical laboratory test (bloodbiochemistry, hematology, and urinalysis)", 
                "safety_issue": "Yes", 
                "time_frame": "From baseline to 16 weeks after the last dose of study drug"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02039505"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Percentage of subjects randomized to the induction phase showing clinical remission (the complete Mayo score is \u2264 2 and all subscores are \u2264 1) at Week 10 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Induction Phase:  Clinical remission at Week 10", 
                "safety_issue": "No", 
                "time_frame": "at Week 10"
            }, 
            {
                "description": "Percentage of subjects randomized to the induction phase showing mucosal healing (the endoscopic subscore of the complete Mayo score is \u2264 1) at Week 10 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Induction Phase: Mucosal healing at Week 10", 
                "safety_issue": "No", 
                "time_frame": "At Week 10"
            }, 
            {
                "description": "Percentage of subjects randomized to the maintenance phase showing clinical response (complete Mayo score decreased \u2265 3 points and \u226530 percent from baseline, and the rectal bleeding subscore decreased  \u2265 1 point from baseline or is \u2264 1) at both Week 10 and 60 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Maintenance Phase:  Durable clinical response", 
                "safety_issue": "No", 
                "time_frame": "At Week 10 and Week 60"
            }, 
            {
                "description": "Percentage of subjects randomized to the maintenance phase showing mucosal healing (the endoscopic subscore of the complete Mayo score is \u2264 1) at Week 60 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Maintenance Phase: Mucosal healing at Week 60", 
                "safety_issue": "No", 
                "time_frame": "At week 60"
            }, 
            {
                "description": "Percentage of subjects randomized to the maintenance phase showing clinical remission (the complete Mayo score is \u2264 2 and all subscores are \u22641) at both Week 10 and 60 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Maintenance Phase:  Durable clinical remission", 
                "safety_issue": "No", 
                "time_frame": "At Week 10 and Week 60"
            }, 
            {
                "description": "Percentage of subjects randomized to the maintenance phase who were using corticosteroids at initiation of study drug treatment, but are not using corticosteroids and show clinical remission (the complete Mayo score is \u22642 and all subscores are \u22641) at Week 60 The Mayo Score is widely used in clinical trials to assess Ulcerative Colitis disease activity. It is a combination of two patient-reported and two physician-determined components. The Mayo score ranges from 0\u221212, with higher scores indicating more severe disease.", 
                "measure": "Maintenance Phase:  Corticosteroid-free clinical remission at Week 60", 
                "safety_issue": "No", 
                "time_frame": "At Week 60"
            }, 
            {
                "description": "Summary statistics for serum Vedolizumab concentration at each evaluation time point", 
                "measure": "Serum Vedolizumab concentration", 
                "safety_issue": "No", 
                "time_frame": "From Week 2 to Week 60"
            }, 
            {
                "description": "Tabulation of incidence of Human anti-human antibody (HAHA)", 
                "measure": "Human anti-human antibody (HAHA)", 
                "safety_issue": "No", 
                "time_frame": "From baseline to 16 weeks after the last dose of study drug"
            }, 
            {
                "description": "Tabulation of incidence of neutralizing antibody", 
                "measure": "Neutralizing antibody", 
                "safety_issue": "No", 
                "time_frame": "From baseline to 16 weeks after the last dose of study drug"
            }
        ], 
        "source": "Takeda", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Takeda", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}